RSMDF
Price
$16.63
Change
+$0.06 (+0.36%)
Updated
Aug 12 closing price
Capitalization
40.32B
55 days until earnings call
SAFLF
Price
$1.50
Change
+$0.21 (+16.28%)
Updated
Aug 13 closing price
Capitalization
700.35M
Interact to see
Advertisement

RSMDF vs SAFLF

Header iconRSMDF vs SAFLF Comparison
Open Charts RSMDF vs SAFLFBanner chart's image
Resmed
Price$16.63
Change+$0.06 (+0.36%)
Volume$159
Capitalization40.32B
Safilo Group Spa
Price$1.50
Change+$0.21 (+16.28%)
Volume$126.74K
Capitalization700.35M
RSMDF vs SAFLF Comparison Chart in %
Loading...
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RSMDF vs. SAFLF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSMDF is a Hold and SAFLF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (RSMDF: $16.57 vs. SAFLF: $1.50)
Brand notoriety: RSMDF and SAFLF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: RSMDF: 3% vs. SAFLF: 390%
Market capitalization -- RSMDF: $40.32B vs. SAFLF: $700.35M
RSMDF [@Pharmaceuticals: Other] is valued at $40.32B. SAFLF’s [@Pharmaceuticals: Other] market capitalization is $700.35M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RSMDF’s FA Score shows that 1 FA rating(s) are green whileSAFLF’s FA Score has 0 green FA rating(s).

  • RSMDF’s FA Score: 1 green, 4 red.
  • SAFLF’s FA Score: 0 green, 5 red.
According to our system of comparison, SAFLF is a better buy in the long-term than RSMDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RSMDF’s TA Score shows that 5 TA indicator(s) are bullish while SAFLF’s TA Score has 3 bullish TA indicator(s).

  • RSMDF’s TA Score: 5 bullish, 3 bearish.
  • SAFLF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, RSMDF is a better buy in the short-term than SAFLF.

Price Growth

RSMDF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while SAFLF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.60%. For the same industry, the average monthly price growth was +5.92%, and the average quarterly price growth was +15.12%.

Reported Earning Dates

RSMDF is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.60% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RSMDF($40.3B) has a higher market cap than SAFLF($700M). RSMDF has higher P/E ratio than SAFLF: RSMDF (17.49) vs SAFLF (11.51). SAFLF YTD gains are higher at: 53.014 vs. RSMDF (-27.058). RSMDF has higher annual earnings (EBITDA): 1.92B vs. SAFLF (107M). RSMDF has more cash in the bank: 1.21B vs. SAFLF (72.6M). SAFLF has less debt than RSMDF: SAFLF (115M) vs RSMDF (852M). RSMDF has higher revenues than SAFLF: RSMDF (5.15B) vs SAFLF (999M).
RSMDFSAFLFRSMDF / SAFLF
Capitalization40.3B700M5,757%
EBITDA1.92B107M1,797%
Gain YTD-27.05853.014-51%
P/E Ratio17.4911.51152%
Revenue5.15B999M515%
Total Cash1.21B72.6M1,665%
Total Debt852M115M741%
FUNDAMENTALS RATINGS
RSMDF vs SAFLF: Fundamental Ratings
RSMDF
SAFLF
OUTLOOK RATING
1..100
3450
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
62
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9037
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5033

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RSMDF's Valuation (29) in the null industry is somewhat better than the same rating for SAFLF (62). This means that RSMDF’s stock grew somewhat faster than SAFLF’s over the last 12 months.

SAFLF's Profit vs Risk Rating (77) in the null industry is in the same range as RSMDF (100). This means that SAFLF’s stock grew similarly to RSMDF’s over the last 12 months.

SAFLF's SMR Rating (100) in the null industry is in the same range as RSMDF (100). This means that SAFLF’s stock grew similarly to RSMDF’s over the last 12 months.

SAFLF's Price Growth Rating (37) in the null industry is somewhat better than the same rating for RSMDF (90). This means that SAFLF’s stock grew somewhat faster than RSMDF’s over the last 12 months.

SAFLF's P/E Growth Rating (100) in the null industry is in the same range as RSMDF (100). This means that SAFLF’s stock grew similarly to RSMDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSMDFSAFLF
RSI
ODDS (%)
Bullish Trend 2 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
43%
Momentum
ODDS (%)
Bullish Trend 2 days ago
40%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
Bearish Trend 2 days ago
37%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
37%
Bullish Trend 2 days ago
27%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
34%
Bullish Trend 2 days ago
22%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
58%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
34%
Bullish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAFLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAMI51.270.63
+1.24%
Acadian Asset Management Inc
IBEX29.530.12
+0.41%
IBEX Limited
BPYPM16.24N/A
N/A
Brookfield Property Partners LP
NYT59.74-0.09
-0.15%
New York Times Co
UEIC4.91-0.09
-1.80%
Universal Electronics

RSMDF and

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
NAOV - RSMDF
30%
Poorly correlated
-4.30%
RMD - RSMDF
20%
Poorly correlated
-2.33%
PFGTF - RSMDF
19%
Poorly correlated
N/A
POSC - RSMDF
9%
Poorly correlated
-4.71%
SAFLF - RSMDF
9%
Poorly correlated
N/A
More

SAFLF and

Correlation & Price change

A.I.dvisor tells us that SAFLF and GMED have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAFLF and GMED's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SAFLF
1D Price
Change %
SAFLF100%
N/A
GMED - SAFLF
28%
Poorly correlated
-0.62%
MYGN - SAFLF
24%
Poorly correlated
+4.89%
JMPHF - SAFLF
23%
Poorly correlated
N/A
OFIX - SAFLF
22%
Poorly correlated
-0.67%
MROPF - SAFLF
21%
Poorly correlated
N/A
More